ILMNIllumina, Inc.
- Headquarters
- San Diego, CA
- CEO
- Jacob Thaysen
- Next results
- around Jan 12, 2027
What changed
10-K filed Feb 12, 2026 against Feb 12, 2025| Area | What changed | Source |
|---|---|---|
| Risk factors | 7 new paragraphs, nothing like them in the previous 10-K | 10-K Item 1A |
| Receivables growing faster than revenue | Receivables +16.2% vs revenue -0.7% (+16.9 pts) | 10-K · XBRL |
| Critical audit matters changed | New this year: Valuation of Excess and Obsolete Inventory (“The Company's inventories totaled $564 million as of December 28, 2025. As explained in Note 1 and Note 7 to the consolidated financial statements, the Company assesses the valuation of inventory each reporting period. Obsolete inventory or inventory in excess of management's estimated usage require”). No longer listed: GRAIL Contingent Consideration; Impairment assessment of GRAIL in-process research and development (IPR&D) | 10-K · XBRL |
| Accounting checks | 9 other checks clear, 2 worth a look | 10-K · XBRL |
| Insiders | No open-market buys in the last 90 days | Form 4 |
| Filings | 3 in the last 30 days | EDGAR |
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
What's new, in their words
10-K filed Feb 12, 2026Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-12. Quoted as filed.
In addition, a reduction or delay in research and development budgets and government funding may adversely affect our business. Many of our customers’, and a portion of our own, research and development and other activities have been funded, or may be funded in the future, by government grants, including from the U.S. National…
10-K, Item 1A
Accounting checks
latest 10-K9 of 11 clear 2 worth a look. Checks, not verdicts.
- !Receivables growing faster than revenueReceivables +16.2% vs revenue -0.7% (+16.9 pts)
- !Critical audit matters changedNew this year: Valuation of Excess and Obsolete Inventory (“The Company's inventories totaled $564 million as of December 28, 2025. As explained in Note 1 and Note 7 to the consolidated financial statements, the Company assesses the valuation of inventory each reporting period. Obsolete inventory or inventory in excess of management's estimated usage require”). No longer listed: GRAIL Contingent Consideration; Impairment assessment of GRAIL in-process research and development (IPR&D)
- ✓Cash from operations $1.1B vs net income $850.0M (FY ending 2025-12-28)
- ✓Inventory +3.1% vs revenue -0.7% (+3.8 pts)
- ✓Same auditor in both 10-Ks: Ernst & Young LLP
- ✓No statement of substantial doubt about going concern
- ✓No 8-K item 4.02 in the last 2 years
- ✓No NT 10-K or NT 10-Q in the last 2 years
- ✓No sentence in the 10-K concludes that controls were not effective because of a material weakness
- ✓No 8-K item 2.06 in the last 2 years
- ✓No 8-K item 1.03 in the last 2 years
In the last 30 days
All filings →- Oct 30, 202610-Q Quarterly report (10-Q) period ended Sep 27, 2026
- Oct 29, 20268-K Quarterly results 8-K item 2.02
- Oct 13, 20268-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q.
RSS feed
Work on ILMN in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ILMN/export.csv") into a cell.